Abstract Details

Title Factors Associated with Significant Reduction in Migraine Headache Days: A Post Hoc Analysis of a Phase II Placebo-Controlled Trial in Patients Treated with Galcanezumab

Topic Headache

Presentation(s) P2 - (-)

Poster/Presentation
Number 177

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Sheena K. Aurora, MD (Department of Neurology and Neurological Sciences) PRESENTER	Dr. Aurora has received personal compensation for serving as an employee of Alzheimer's Association.
Tina Oakes	Tina Oakes has received personal compensation for serving as an employee of Eli Lilly. Tina Oakes has received stock or an ownership interest from Eli Lilly.
Qi Zhang, MD, PhD (Eli Lilly and Company)	No disclosure on file
	No disclosure on file
James Martinez	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��